Patents by Inventor David M. Ockert

David M. Ockert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of pain with naloxone
    Publication number: 20080171762
    Abstract: A method of effectively treating nociceptive pain involves administering to a human or animal in need of relief from nociceptive pain a therapeutically effective amount of naloxone intranasally, intravenously, by inhalation, transdermally, or orally. Pain associated with fibromyalgia, arthritis, surgical procedures, etc. can be effectively treated.
    Type: Application
    Filed: January 16, 2007
    Publication date: July 17, 2008
    Inventor: David M. Ockert
  • Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
    Patent number: 6503950
    Abstract: A triple drug, pharmaceutical kit, composition, and method of treatment containing a combination of effective amounts of at least one anxiolytic agent, at least one centrally acting alpha antiadrenergic agent, and at least one central nervous system stimulant for the reduction or prevention of alcohol and narcotic withdrawal side effects of dizziness, drowsiness, depression, lethargy, orthostatic hypotension, weakness in the extremities, and difficulty in being mobile, caused by therapeutic agents utilized for the treatment of alcohol or narcotic withdrawal symptoms in patients overcoming alcohol or narcotic addiction.
    Type: Grant
    Filed: August 8, 2000
    Date of Patent: January 7, 2003
    Inventor: David M. Ockert
  • Triple drug therapy for the treatment and prevention of acute or chronic pain
    Patent number: 6417184
    Abstract: A triple drug therapy, pharmaceutical kit, composition, and method of treatment regimen utilized as a combination of effective amounts of an anxiolytic agent, centrally acting alpha antiadrenergic agent, and central nervous system stimulant for the reduction or prevention of dizziness, drowsiness, depression, delirium, lethargy, mania, orthostatic hypotension, restlessness, weakness in the extremities, and difficulty in being mobile negative side effects caused by therapeutic agents utilized in the treatment of acute and chronic pain syndromes.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: July 9, 2002
    Inventor: David M. Ockert
  • Triple drug therapy for the treatment and prevention of acute or chronic pain
    Publication number: 20020058656
    Abstract: A triple drug therapy, pharmaceutical kit, composition, and method of treatment regimen utilized as a combination of effective amounts of an anxiolytic agent, centrally acting alpha antiadrenergic agent, and central nervous system stimulant for the reduction or prevention of dizziness, drowsiness, depression, delirium, lethargy, mania, orthostatic hypotension, restlessness, weakness in the extremities, and difficulty in being mobile negative side effects caused by therapeutic agents utilized in the treatment of acute and chronic pain syndromes.
    Type: Application
    Filed: August 17, 2001
    Publication date: May 16, 2002
    Inventor: David M. Ockert
  • Method of attenuating nerve injury induced pain
    Patent number: 5376662
    Abstract: The specification discloses a method of treating a human or animal patient suffering from a pain syndrome secondary to nerve injury comprising daily administration to such patient of from about 0.4 milligrams to about 2.0 milligrams of the opiate-receptor antagonist naloxone for a treatment period of from around 3 months to around 12 months, depending upon the patient's needs. Delivery is preferably at or near the nerve injury site by a number of conventional injection methods.
    Type: Grant
    Filed: December 8, 1993
    Date of Patent: December 27, 1994
    Inventor: David M. Ockert